返回 Agenda
Session 1: Increase Value of Publicly Disclosed Clinical Trial Information
Session Chair(s)
Kelly Coulbourne, MS
Director, Clinical Trial Transparency and Disclosure
Pfizer Inc, United States
Session 1: Increase Value of Publicly Disclosed Clinical Trial Information
Speaker(s)
![Representative Invited](/_Images/member/Generic_Image_Missing-Profile.jpg)
How Can Value Be Added to Registration and Results Postings?
Representative Invited
Center For the Study of Drug Development, United States
![Representative Invited](/_Images/member/Generic_Image_Missing-Profile.jpg)
Enabling Individual Participant Data Return (iPDR)
Representative Invited
TransCelerate BioPharma Inc., United States
![Representative Invited](/_Images/member/Generic_Image_Missing-Profile.jpg)
Update on ClinicalTrials.gov Modernization Effort
Representative Invited
National Institutes of Health (NIH), United States